Leukotriene receptor antagonists in chronic urticaria.
Asero
R
R
Ambulatorio di Allergologia, Ospedale Caduti Bollatesi, Via Piave 20 20021 Bollate (MI), Italy.
Tedeschi
A
A
Lorini
M
M
D000085:Acetates / Q000276:immunology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003521:Cyclopropanes; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007211:Indoles; D020024:Leukotriene Antagonists / Q000276:immunology / Q000627:therapeutic use*; D015289:Leukotrienes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D048448:Phenylcarbamates; D011804:Quinolines / Q000276:immunology / Q000627:therapeutic use*; D012074:Remission Induction; D012720:Severity of Illness Index; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000276:immunology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014581:Urticaria / Q000145:classification / Q000188:drug therapy* / Q000276:immunology
D000085:Acetates; D003521:Cyclopropanes; D007211:Indoles; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D048448:Phenylcarbamates; D011804:Quinolines; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds; C093875:montelukast; C062735:zafirlukast